Literature DB >> 14754662

Effects of cigarette smoking on cognitive processing.

Meral Aşçioglu1, Nazan Dolu, Asuman Gölgeli, Cem Süer, Cigdem Ozesmi.   

Abstract

Several previous studies have reported that cigarette smoking enhances performance of cognitive processing. These enhancements are generally attributed to the pharmacological effects of nicotine, while there is some debate whether the effects of smoking/nicotine are a result of recovery from abstinence. Evoked potentials (EPs) and event related potentials (ERPs) of the brain have been applied as an index of information processing in a wide variety of normal and cognitive impaired subjects. This study was carried out on 20 healthy students (23 +/- 2.3 years old) from the medical faculty of City University. Study population comprised ten chronic cigarette smokers consuming an average of 14 +/- 4.2 cigarettes per day, with a history of smoking for more than one year. Ten non -smokers served as control. Standard oddball paradigm was presented, and EEG activity was recorded at the Fz, Cz, Pz electrode sites. Twenty responses to target stimuli were averaged at each location. N1, P2, N2, and P300 components were evaluated in these recordings. Amplitudes were measured relative to prestimulus baseline, and peak latencies were defined as the time point of maximum amplitude. It was found that there were no significant differences between either N1, P2, N2, P300 amplitudes or peak latency values of cigarette smokers and non smokers. As a result, chronic cigarette smoking generally does not improve cognitive processing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14754662     DOI: 10.1080/00207450490270668

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  8 in total

1.  Effects of trifluoromethylphenylpiperazine (TFMPP) on interhemispheric communication.

Authors:  HeeSeung Lee; Rob R Kydd; Vanessa K Lim; Ian J Kirk; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2010-10-06       Impact factor: 4.530

Review 2.  Nicotinic modulation of neuronal networks: from receptors to cognition.

Authors:  Huibert D Mansvelder; Karlijn I van Aerde; Jonathan J Couey; Arjen B Brussaard
Journal:  Psychopharmacology (Berl)       Date:  2005-07-02       Impact factor: 4.530

3.  Obesity, smoking, and frontal brain dysfunction.

Authors:  Lance Bauer; Danielle Dick; Laura Bierut; Kathleen Bucholz; Howard Edenberg; Samuel Kuperman; John Kramer; John Nurnberger; Sean O'Connor; John Rice; John Rohrbaugh; Marc Schuckit; Jay Tischfield; Bernice Porjesz; Victor Hesselbrock
Journal:  Am J Addict       Date:  2010 Sep-Oct

Review 4.  Recent EEG and ERP findings in substance abusers.

Authors:  Natalie A Ceballos; Lance O Bauer; Rebecca J Houston
Journal:  Clin EEG Neurosci       Date:  2009-04       Impact factor: 1.843

5.  Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment.

Authors:  James Prosser; Lisa J Cohen; Matthew Steinfeld; Daniel Eisenberg; Edythe D London; Igor I Galynker
Journal:  Drug Alcohol Depend       Date:  2006-03-20       Impact factor: 4.492

Review 6.  Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.

Authors:  Douglas L Boggs; Jon Carlson; Jose Cortes-Briones; John H Krystal; D Cyril D'Souza
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

7.  Exposure to Nicotine Vapor Produced by an Electronic Nicotine Delivery System Causes Short-Term Increases in Impulsive Choice in Adult Male Rats.

Authors:  Rodolfo J Flores; Fatima Z Alshbool; Priscilla Giner; Laura E O'Dell; Ian A Mendez
Journal:  Nicotine Tob Res       Date:  2022-02-14       Impact factor: 5.825

8.  Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans.

Authors:  Daniel H Mathalon; Kyung-Heup Ahn; Edward B Perry; Hyun-Sang Cho; Brian J Roach; Rebecca K Blais; Savita Bhakta; Mohini Ranganathan; Judith M Ford; Deepak Cyril D'Souza
Journal:  Front Psychiatry       Date:  2014-01-24       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.